• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Why One Korean Biotech Picked New Jersey for U.S. Headquarters

Article

Pharmaceutical Executive

New Jersey is still a top pick for companies when it comes to pharma.

Ki-Young Sohn, chairman and CEO of Enzychem Lifesciences, explains why the company selected New Jersey as the location for their U.S. offices.

He spoke to Pharm Exec during a company event in New York City.

 

Related Videos
Related Content
The Pharmaceutical Playbook for Asia’s Private Market

The Pharmaceutical Playbook for Asia’s Private Market

April 11th 2024
Article

Is it possible to win in Asia’s private market?

Bruce Liu

Fresh Formulas for Growth: Assessing Asia in the New Year

February 8th 2024
Article

The three key themes likely to shape pharma fortunes in 2024.

Adam Zhang

Out-licensing Deals Between Chinese Pharma and Global Companies are Heating Up

January 19th 2024
Article

A growing number of domestic drug developers are setting their sights on overseas markets.

Professor F. Warren McFarlan, DBA, MBA, AB

Should Biopharma C-Suites Still Engage With China? A Harvard Business School Healthcare Alumni Association Q&A with Professor F. Warren McFarlan

November 16th 2023
Article

An overview of what biopharma C-Suites and their boards should consider when engaging with government and business leaders from China, the world’s second largest economy.

Ramees Raja

Q&A With Ramees Raja, Global Energy Manager at Almac Group

November 3rd 2023
Article

Raja discusses how the pharma industry can improve its ecological impact.

Bruce Liu

The Rising Importance of Patient Advocacy Innovations in Asia

October 11th 2023
Article

Effective engagement—from research to reimbursement—is key.